EUVIMEDEUVIMED entdecken
Crossref

Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine

Monika Udziela, Bartosz Sapilak

OphthaTherapy. Therapies in Ophthalmology · 29.10.2025 · 12 (3) · 248-251

DOI: 10.24292/01.ot.001225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OphthaTherapy. Therapies in Ophthalmology, online erschienen am 29.10.2025. Verfasst von Monika Udziela und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Red eye is a symptom which may indicated different disorders. Mild hyperemia may occur without any defined aetiology and may cause esthetical and psychological problems for the patients. Diagnostics is crucial before implementing the symptomatic treatment to exclude any disease requiring targeted therapy. All cases of red eye symptom with pain and visual disturbances require special attention. Eyedrops with low-dose brimonidine are good alternative to other vasoconstrictors, as safe and well-tolerated medication not leading to hypoxia, tachyphylaxis and rebound effect.

Zitieren

APA

Udziela, M., & Sapilak, B. (2025). Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine. OphthaTherapy. Therapies in Ophthalmology, 12(3), 248-251. https://doi.org/10.24292/01.ot.001225

Vancouver

Udziela M, Sapilak B. Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine. OphthaTherapy. Therapies in Ophthalmology. 2025;12(3):248-251. doi:10.24292/01.ot.001225

BibTeX
@article{Udziela2025,
  author = {Udziela, Monika and Sapilak, Bartosz},
  title = {Red eye. Ophthalmologist’s and General Practitioner’s point of view. Therapy with low-dose brimonidine},
  journal = {OphthaTherapy. Therapies in Ophthalmology},
  year = {2025},
  volume = {12},
  number = {3},
  pages = {248--251},
  doi = {10.24292/01.ot.001225}
}
Kostenlos starten →